Praxis Precision Medicines Stock Rockets Upward as Major Investor Increases Stake to Record Levels
The biotechnology sector witnessed a rare and breathtaking rally this week as Praxis Precision Medicines captured the full attention of Wall Street.
by 
Josh Weiner
Josh Weiner